Publications
2023
01/05/2023
Canagliflozin Attenuates PromarkerD Diabetic Kidney Disease Risk Prediction Scores
23/02/2023
Semi-Automated Lectin Magnetic Bead Array (LeMBA) for Translational Serum Glycoprotein Biomarker Discovery and Validation
23/02/2023
Immunoaffinity Mass Spectrometry Diagnostic Tests for Multi-Biomarker Assays
2022
30/10/2022
Comparative Sub-cellular Proteome Analyses Reveals Metabolic Differentiation and Production of Effector-like Molecules in the Dieback Phytopathogen Phytophthora Cinnamomi
2020
28/10/2020
The New and the Old: Platform Cross-Validation of Immunoaffinity MASS Spectrometry versus ELISA for PromarkerD, a Predictive Test for Diabetic Kidney Disease
20/10/2020
A robust multiplex immunoafnity mass spectrometry assay (PromarkerD) for clinical prediction of diabetic kidney disease
09/10/2020
From Nanoflow to Standard Flow LC/MS for Routine Quantitative Plasma Proteomics in Diabetic Kidney Disease Research
06/10/2020
PromarkerD Predicts Renal Function Decline in Type 2 Diabetes in the Canagliflozin Cardiovascular Assessment Study (CANVAS)
31/03/2020
Peptide analysis of mammalian decomposition fluid in relation to the post-mortem interval
10/01/2020
Protein Network Analysis Identifies Changes in the Level of Proteins Involved in Platelet Degranulation, Proteolysis and Cholesterol Metabolism Pathways in AECOPD Patients
Newsroom
Categories
Biomarker Discovery
Clinical
Clinical Utility
Drug Discovery
iTRAQ
Method Development
Proteogenomics
Proteomics
1
2
3
4
5
Subscribe
Subscripe to:
All Company news and updates
PromarkerD updates
PromarkerEso updates
PromakerEndo updates
Title
Name
*
Position
Company/Organisation
*
Phone
Email
*
Terms & Conditions
*
I accept the terms and conditions
Comments
This field is for validation purposes and should be left unchanged.
VISIT OUR NEW WEBSITE
Investor Relations
ASX Announcements
Share Price and Analyst Coverage
Library
Reports
Corporate Governance
Shareholder Information
Annual General Meeting